STOCK TITAN

Insider for company (NASDAQ: SOPH) plans sale of 30,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 for SOPH reports a proposed sale of 30,000 shares of common stock with an aggregate market value of $144,000.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 01/07/2026, and the stock is listed on NASDAQ, where 67,847,058 common shares are shown as outstanding.

The securities to be sold include 17,933 common shares acquired on 01/07/2026 via exercise of stock options for cash and 12,067 founder shares acquired on 03/18/2021. The filing also lists prior Rule 10b5-1 sales for JURGI CAMBLONG over the past three months, such as 16,948 common shares sold on 01/06/2026 for gross proceeds of 81,669.02 and 24,641 shares sold on 10/30/2025 for 123,942.82.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does SOPH's Form 144 filing disclose?

The Form 144 notice discloses a proposed sale of 30,000 shares of SOPH common stock with an aggregate market value of 144,000.00, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 01/07/2026 on NASDAQ.

How many SOPH shares are planned to be sold under this Form 144?

The filing indicates an intention to sell 30,000 shares of common stock, with an aggregate market value listed as 144,000.00.

How were the SOPH shares in this Form 144 acquired?

The securities to be sold include 17,933 common shares acquired on 01/07/2026 through an exercise of stock options paid in cash, and 12,067 founder shares acquired on 03/18/2021 from the issuer.

What is the total number of SOPH shares outstanding mentioned in the Form 144?

The Form 144 lists 67,847,058 common shares as outstanding for SOPH in connection with the proposed sale information.

Which broker and exchange are involved in the SOPH Form 144 sale?

The proposed sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are listed for trading on the NASDAQ exchange.

What recent Rule 10b5-1 sales related to SOPH are listed in the Form 144?

The filing lists multiple Rule 10b5-1 sales for JURGI CAMBLONG over the past three months, including 16,948 common shares sold on 01/06/2026 for gross proceeds of 81,669.02 and 24,641 shares sold on 10/30/2025 for 123,942.82.

Sophia Genetics Sa

NASDAQ:SOPH

View SOPH Stock Overview

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

319.64M
63.48M
Health Information Services
Healthcare
Link
Switzerland
Rolle